Haemonetics Corporation Completes Acquisition of OpSens
Haemonetics acquired all outstanding shares of OpSens for CAD $2.90 per share in the all-cash transaction, representing a…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Dec 23
Haemonetics acquired all outstanding shares of OpSens for CAD $2.90 per share in the all-cash transaction, representing a…
08 Dec 23
The single-arm Investigational Device Exemption APEX-AV study is intended to assess the efficacy and safety of the AlphaVac…
07 Dec 23
Kaneka manufactures and sells endovascular catheters, which are devices used in the treatment of cardiac, peripheral vascular, and…
04 Dec 23
In the study conducted by Centre EuropĂ©en de Recherche Cardiovasculaire (CERC), the participants received the Colibri dry tissue…
01 Dec 23
Laminar's rotational motion device is designed to eliminate the left atrial appendage by rotational motion in contrast to…
01 Dec 23
Argon Medical Devices earned a reputation for delivering innovative products, superior service, and exceptional value for Interventional Radiologists,…
28 Nov 23
The PenditureTM Left Atrial Appendage (LAA) Exclusion System is for the exclusion of the LAA in patients undergoing…
23 Nov 23
Brainomix 360 is an advanced stroke AI platform intended to aid physicians in making imaging-based therapy decisions at…
22 Nov 23
Supira system is a next-generation percutaneous ventricular assist device (pVAD) intended to provide full hemodynamic support initially for…
21 Nov 23
PMcardio, leveraging insights from a database of over 500,000 patients, detects heart attacks with double the sensitivity compared…